27.38
price up icon2.09%   0.55
after-market Handel nachbörslich: 27.38
loading

Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten

pulisher
09:35 AM

After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Rigel (RIGL) - Yahoo Finance

09:35 AM
pulisher
05:38 AM

Is Rigel Pharmaceuticals Inc. stock a contrarian buyTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com

05:38 AM
pulisher
05:24 AM

Can Rigel Pharmaceuticals Inc. (RI2) stock double in coming years2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com

05:24 AM
pulisher
04:40 AM

Rigel Pharmaceuticals Inc. stock volume spike explainedAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com

04:40 AM
pulisher
04:05 AM

Can Rigel Pharmaceuticals Inc. stock deliver strong Q4 earningsLong Setup & Daily Volume Surge Trade Alerts - newser.com

04:05 AM
pulisher
03:24 AM

Volume spikes in Rigel Pharmaceuticals Inc. stock – what they meanTrade Ideas & Weekly High Momentum Picks - newser.com

03:24 AM
pulisher
Oct 13, 2025

Is this a good reentry point in Rigel Pharmaceuticals Inc.Market Risk Summary & Daily Entry Point Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Momentum divergence signals in Rigel Pharmaceuticals Inc. chartBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What the charts say about Rigel Pharmaceuticals Inc. todayWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Why Rigel Pharmaceuticals Inc. stock could see breakout soonRisk Management & Daily Profit Focused Screening - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Rigel Pharmaceuticals Inc. stock recession proofWatch List & Weekly Breakout Stock Alerts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

How Rigel Pharmaceuticals’ R289 Trial Progress and FDA Designations Will Impact RIGL Investors - Yahoo Finance

Oct 12, 2025
pulisher
Oct 11, 2025

Rigel Pharmaceuticals (RIGL): Assessing Valuation Following Key Clinical Milestone for R289 - simplywall.st

Oct 11, 2025
pulisher
Oct 10, 2025

Did Rigel's (RIGL) R289 Phase 1b Expansion Just Shift the Company's Pipeline Prospects? - simplywall.st

Oct 10, 2025
pulisher
Oct 10, 2025

Is Rigel Pharmaceuticals Inc. stock reversal real or fakeMarket Trend Report & Safe Capital Growth Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Receives "Hold (C+)" Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

Rigel Pharmaceuticals stock advances as first patient enrolled in R289 study expansion - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Multi factor analysis applied to Rigel Pharmaceuticals Inc.2025 Volume Leaders & Reliable Entry Point Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Published on: 2025-10-09 05:05:12 - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

HC Wainwright & Co. Reiterates Rigel Pharmaceuticals (RIGL) Buy Recommendation - Nasdaq

Oct 08, 2025
pulisher
Oct 08, 2025

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Down 4%What's Next? - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals (RIGL) Rating Reiterated as 'Buy' by HC Wa - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals' (RIGL) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals, Inc. Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals (RIGL) Advances Phase 1b Study with New Pa - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel announces first patient enrolled in dose expansion phase of 1b study of R289 in patients with lower-risk MDS - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Hold" Rating by Zacks Research - MarketBeat

Oct 08, 2025
pulisher
Oct 08, 2025

First patient enrolled: Rigel advances R289 Phase 1b dose expansion, 500 mg qd/bid, up to 40 pts for RP2D - Stock Titan

Oct 08, 2025
pulisher
Oct 06, 2025

Does Rigel Pharmaceuticals Inc. qualify in momentum factor screening2025 Market WrapUp & Fast Momentum Stock Entry Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock profit from fiscal stimulusWeekly Profit Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Analyzing Rigel Pharmaceuticals Inc. with multi timeframe chartsWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Applying Elliott Wave Theory to Rigel Pharmaceuticals Inc.Fed Meeting & Proven Capital Preservation Methods - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Using portfolio simulators with Rigel Pharmaceuticals Inc. included2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Eastern Progress

Oct 04, 2025
pulisher
Oct 03, 2025

Immune Thrombocytopenic Purpura (ITP) Pipeline 2025: Pioneering Clinical Developments by 30+ Global Leaders – DelveInsight | Featuring Sanofi, Takeda, Rigel Pharmaceuticals, Bristol-Myers Squibb - Barchart.com

Oct 03, 2025
pulisher
Oct 03, 2025

Rigel Pharmaceuticals announces inducement grants - MarketScreener

Oct 03, 2025
pulisher
Oct 03, 2025

A Deep Dive Into Rigel Pharmaceuticals (RIGL) Valuation After Voya Investment Management Expands Stake - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about Rigel Pharmaceuticals Inc RI2 stockStock Buyback Updates & Free Rapid Wealth Multiplication - earlytimes.in

Oct 02, 2025
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):